공지사항

Omodulin: protectorate God of the vasculature in thrombosis and inflammation. J Thromb Haemost 2011, 9(Suppl 1):168?73. 13. Sitrin RG, Pan PM, Srikanth S, Todd RF 3rd: Fibrinogen activates NF-kappa B transcription factors in mononuclear phagocytes. J Immunol 1998, 161:1462?470. 14. Okamoto T, Tanigami H, Suzuki K, Shimaoka M: Thrombomodulin: a bifunctional modulator of inflammation and coagulation in sepsis. Crit Care Res Pract 2012, 2012:614545. 15. Johnson K, Choi Y, DeGroot E, Samuels I, Creasey A, Aarden L: Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation. J Immunol 1998, 160:5130?135. s40337-016-0117-z 16. Riedemann NC, Guo RF, Ward PA: Novel strategies for the treatment of sepsis. Nat Med 2003, 9:517?24. 17. Kumagai M, Horiguchi T, Nishikawa T, Masaki Y, Tobe Y: Intravenous dexmedetomidine decreases lung permeability induced by intracranial hypertension in rats. Anesth Analg 2008, 107:643?47. 18. Teke Z, Sacar M, Yenisey C, Atalay AO, Bicakci T, Erdem E: Activated protein C attenuates intestinal reperfusion-induced acute lung injury: an experimental study in a rat model. Am J Surg 2008, 195:861?73.Iwashita et al. Journal of Intensive Care 2014, 2:57 http://www.jintensivecare.com/content/2/1/Page 10 of19. Yamada PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/12027669 Y, Maruyama J, Zhang E, Okada A, Yokochi A, Sawada H, Mitani Y, Hayashi T, Suzuki K, Maruyama K: Effect of thrombomodulin on the development of monocrotaline-induced pulmonary hypertension. J Anesth 2014, 28:26?3. 20. Maruyama J, Maruyama K, Mitani Y, Kitabatake M, 3-(2,4-Dichlorophenoxy)azetidine Yamauchi T, Miyasaka K: Continuous low-dose NO inhalation does not prevent monocrotalineinduced pulmonary hypertension in rats. Am J Physiol 1997, 272:H517 524. 21. DiRocco JD, Pavone LA, Carney DE, Lutz CJ, Gatto LA, Landas SK, Nieman GF: Dynamic alveolar mechanics in four models of lung injury. Intensive Care Med 2006, 32:140?48. 22. Li LF, Liao SK, Ko YS, Lee CH, Quinn DA: Hyperoxia increases ventilator-induced lung injury via mitogen-activated protein kinases: a prospective, controlled animal experiment. Crit Care 2007, 11:R25. 23. Wilson MR, Choudhury S, Goddard ME, O'Dea KP, Nicholson AG, Takata M: High tidal volume upregulates intrapulmonary cytokines in an in vivo mouse model of ventilator-induced lung injury. J Appl Physiol 2003, 95:1385?393. 24. Zapol WM, Snider MT: Pulmonary hypertension in severe acute respiratory failure. N Engl J Med 1977, 296:476?80. 25. Maruyama K, Maruyama J, Utsunomiya H, Furuhashi K, Kurobuchi M, Katayama Y, Yada I, PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/9544797 Muneyuki M: Effect of nicardipine on pulmonary hypertension after repair of congenital heart defects in early postoperative period. J Anesth 1993, 7:95?01. 26. Andersson U, Tracey KJ: HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 2011, 29:139?62. 27. Narimanbekov IO, Rozycki HJ: Effect of IL-1 blockade on inflammatory manifestations of acute ventilator-induced lung injury in a rabbit Methyl 3-fluoro-2-thiophenecarboxylate model. Exp Lung Res 1995, 21:239?54. 28. Conway EM, Rosenberg RD: Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol Cell Biol 1988, 8:5588?592. 29. Wojciak-Stothard B, Ridley AJ: Rho GTPases and the regulation of endothelial permeability. Vascul Pharmacol 2002, 39:187?99. 30. Mohri M, Gonda Y, Oka M, Aoki Y, Gomi K, Kiyota T, Sugihara T, Yamamoto S, Ishida T, Maruyama I: The antithrombotic effects of recombinant human soluble thrombomodulin (rhsTM) on tissue factor-induced disseminated intravascular coagulation in crab.